← back to search

Joel R. Neilson

Baylor College of Medicine · US
Area of research
Molecular Biology · Atomic and Molecular Physics, and Optics
Research interest
Research interests include Gyrotron and Vacuum Electronics Research, RNA modifications and cancer, RNA Research and Splicing, and Particle accelerators and beam dynamics.
h-index
43
citations
13,591
works
138
NIH funding
primary concept
email

Recent publications

CELF1 is a non-canonical eIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs.
2026cited by 0position: contributordoi
Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy
Nature Communications 2022cited by 33position: middledoi
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis
Nature Cancer 2020cited by 127position: middledoi
Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease
Cell Metabolism 2019cited by 181position: middledoi
Differences between acute and chronic stress granules, and how these differences may impact function in human disease.
2019cited by 87position: contributordoi
MiR-146a wild-type 3' sequence identity is dispensable for proper innate immune function in vivo.
2019cited by 6position: contributordoi
3′ UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk
Nature Genetics 2018cited by 197position: middledoi
Differences between acute and chronic stress granules, and how these differences may impact function in human disease
Biochemical Pharmacology 2018cited by 109position: lastdoi
mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases
Nature Communications 2017cited by 433position: middledoi
Glycolysis determines dichotomous regulation of T cell subsets in hypoxia
Journal of Clinical Investigation 2016cited by 109position: middledoi
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Nature 2015cited by 521position: middledoi
NUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylation
eLife 2015cited by 82position: middledoi
Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types
Nature Communications 2014cited by 629position: middledoi
CD44 promotes Kras-dependent lung adenocarcinoma
Oncogene 2012cited by 56position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Arindam Chaudhury · Baylor College of Medicine5 papers (2015–2022)Wei Li · Harbin Medical University3 papers (2014–2018) · 2 papers (2019–2026)Eric J. Wagner · Saint John Regional Hospital2 papers (2014–2018)Lucas C. Reineke · Codexis (United States)2 papers (2018–2022)Zheng Xia · Oregon Health & Science University2 papers (2014–2018)Leonid S. Metelitsa · Houston Methodist1 papers (2016–2016)Soyeon Kim · Broad Institute1 papers (2018–2018)Jun Liu · Chongqing Medical University1 papers (2020–2020)Weijie Zhang · Fuwai Yunnan Cardiovascular Hospital1 papers (2020–2020)Lei Li · University of North Texas1 papers (2018–2018)Ming Zhang · Hebei Medical University1 papers (2016–2016)Hai Wang · University of South China1 papers (2020–2020)Lan Lu · Guangzhou Medical University1 papers (2019–2019)Hyun Jung Park · Naval Aerospace Medical Institute1 papers (2018–2018)Hannah L. Johnson · Kent State University1 papers (2019–2019)David Watkins · McGill University Health Centre1 papers (2022–2022)Ping Ji · University of Rochester Medical Center1 papers (2018–2018)Parisa Lotfi · Yale University1 papers (2017–2017) · 1 papers (2015–2015)